| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3cd3ea6c52ef8544c67c051a2ef489b3 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-421
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-423
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-421 |
| filingDate |
2017-02-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_711fbbce79f861f7be084f759083a60a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_edf266cb13d7566675bd5ed2c85c93b1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a5020d6460dc54a87f0cf98bc770fc67 |
| publicationDate |
2018-03-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CA-3032630-A1 |
| titleOfInvention |
Agent for treatment of pbc |
| abstract |
The purpose of the present invention is to provide a novel therapeutic agent which is useful for the treatment of primary biliary cirrhosis (PBC). The present invention relates to a pharmaceutical composition for treating PBC, which contains a therapeutically effective amount of (R)-2-[3-[[N-(benzoxazol-2-yl)-N-3-(4-methoxyphenoxy)propyl]aminomethyl]phenoxy]butyric acid, a salt of the compound, or a solvate of the compound or the salt. |
| priorityDate |
2016-08-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |